Showing posts with label depression. Show all posts
Showing posts with label depression. Show all posts

2 Nov 2014

Publication highlights

Lung Transplantation as Rescue Therapy
A recent study has looked at an increasing demand for lung transplantation in patients in advanced respiratory failure. Although many of these patients do not require mechanical ventilation or extracorporeal membrane oxygenation, an increasing number are critically ill. The study analyses lung transplantation in subjects who were inpatients at the time of their transplant and not expected to survive to discharge. Click here to read the full study.
 
How do you treat phantom pain?
A recent study co-authored by CCS researcher Dr Carolyn Arnold found that due to the disruption to multiple neural networks in the case of a phantom pain—including sensory and motor, multiple treatment approaches are required. See more.

The Art of Thinking
The European Respiratory Journal is publishing a series of essays by Associate Professor Tom Kotsimbos (Department of Allergy, Immunology and Respiratory medicine) over 2014. The essays feature key pieces of revolutionary European art spanning the last 500 years to spark cross-disciplinary conversations, insights and extrapolations the “Art of Thinking” between the Arts, Science and Philosophy. October's essay looks at the art of Edvard Munch and Gustav Klimt. See more.

Parkinson's and gut biota
CCS researchers conducted a study this year which looked at small intestinal bacterial overgrowth in Parkinson's disease, and a possible association with gastrointestinal symptoms and worse motor function. See more.

Perimenopausal depression is different
MAPrc researchers have published a study which found that symptoms of depression during perimenopause were found to present as subtly different to that seen during the childbearing years, with milder symptoms of depression, increased anger, reduced sleep quality, and increased fatigue that was independent of sleep quality.  See more


6 Apr 2014

Participants sought: Research studies on depression, smoking cessation

Predicting optimized treatment in depression
The purpose of this study is to investigate patient response versus non patient response (i.e “controls” – defined as participants who do not suffer from depression and are not on medication) to antidepressant medications. A combination of brain measures (physical and mental) and body functions will be analysed to determine patient response to antidepressant medications using genetic, psychological and physiological measures. Currently, there are no accurate predictors of how patients will respond to antidepressant treatment.  See more: Link

Smoking cessation, mental health and medication
This study will examine important safety aspects (such as agitation, aggression and depression) of the drugs varenicline and bupropion compared to placebo (“dummy pills” that do not contain any medicine) and nicotine-replacement therapy (NRT or “the patch”) in smokers with or without a history of being diagnosed with a psychiatric disorder. See more: Link

31 Mar 2014

Participants sought for new research studies in gluten, diabetes, depression, schizophrenia

Participants sought: An adjunctive pro-cognitive treatment in schizophrenia
This study by Monash Alfred Psychiatry Research Centre (MAPrc) is being conducted in order to determine if two different doses of EVP-6124 improve mental function and are safe in people who have schizophrenia and are taking another medication for their illness. Contact: Mr Daniel Grice ph (03) 9076 6581 Email participate.maprc@monash.edu Website link: http://www.maprc.org.au/psychopharmacology.